Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Johnson & Johnson (NY: JNJ )

182.12 -0.17 (-0.09%)
Official Closing Price Updated: 4:10 PM EDT, Jun 27, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Johnson & Johnson

< Previous 1 2 3 4 5 6 7 8 9
...
33 34 Next >
From Axcella To Tonix, Here Are The Penny Stocks Of Companies Working On Long Covid
More than four in 10 people in a recent survey knew of someone with long Covid. 
Via Investor's Business Daily
This Biotech Company Says That It's Looking To Deliver A Breakthrough In Psychiatric Medicine — What's The Scoop?
Pasithea Therapeutics Corp. (NASDAQ: KTTA) is a biotech company with a goal of investigating novel drug treatments to provide more effective relief to the estimated 792 million people around the world... 
Via Benzinga
Could This Company's Gastrointestinal Drug Be A Powerful Pill For People And Animals With Chronic, Debilitating Diarrhea?
San Francisco-based Jaguar Health, Inc. (NASDAQ: JAGX), a commercial-stage pharmaceuticals company, says it is focused on developing novel, plant-based, non-opioid and sustainably derived prescription... 
Via Benzinga
With Zero Revenue, Laekna Plays Chicken-And-Egg Game With Investors
Key Takeaways: Laekna is seeking a Hong Kong IPO to raise funds to accelerate the commercialize two core products licensed from Novartis The company currently is not generating... 
Via Benzinga
Why Did HC Wainwright Downgrade Addex Therapeutics
 
Via Benzinga
Legend Biotech Shares Move Higher After Bullish BMO Pitch
 
Via Benzinga
Addex Stops Parkinson's-Associated Dyskinesia Trial - Read Here Why
 
Via Benzinga
7 Large-Cap Stocks to Buy After the Next Big Correction
Large-cap stocks to buy with the broad market correction. Stocks to buy and hold for the long-term for dividends and stock upside. 
Via InvestorPlace
Here's How Much You Would Have Made Owning Johnson & Johnson Stock In The Last 15 Years
Johnson & Johnson (NYSE:JNJ) has outperformed the market over the past 15 years by 1.05% on an annualized basis producing an average annual return of 7.34%. Currently, Johnson & Johnson has a market... 
Via Benzinga
7 Retirement Stocks to Buy After Age 30
Inflation, interest rate hikes, recessions. There's a lot to worry about right now. But these seven retirement stocks can overcome these obstacles. 
Via InvestorPlace
Check Out What Whales Are Doing With JNJ
A whale with a lot of money to spend has taken a noticeably bullish stance on Johnson & Johnson. Looking at options history for Johnson & Johnson (NYSE:JNJ) we detected 20 strange trades. 
Via Benzinga
Bear Market 2022: Is There Anything Left to Invest In?
Bear markets often present the best investment opportunities. Consider the following strategies to profit in this 2022 bear market. 
Via InvestorPlace
Economic Hurricane Ahead? 7 Profitable Places to Hide Your Money
With an economic hurricane on the horizon, investors are searching for alternative investment paths and profitable places to invest in. 
Via InvestorPlace
7 Stocks to Buy If You Have $1,000 to Invest
In a tough market, like we're currently experiencing, the best stocks to buy are those that have sound balance sheets and good prospects. 
Via InvestorPlace
Looking At Johnson & Johnson's Recent Whale Trades
Someone with a lot of money to spend has taken a bearish stance on Johnson & Johnson (NYSE:JNJ). And retail traders should know. We noticed this today when the big position showed up on publicly... 
Via Benzinga
Johnson & Johnson Urges FDA To Take Interim Steps As It Continues To Review CBD
The FDA's Science Board has once again reviewed the idea of incorporating cannabinoids into dietary supplements. 
Via Benzinga
3 Super-Safe Dividend Stocks to Buy
Investors seeking dividend income during times of market instability should consider buying these blue-chip companies. 
Via InvestorPlace
Mistaken Identity? Drink Maker Celsius Falls 10% On Monday
“What’s in a name? That which we call a rose by any other name would smell just as sweet.” A beverage company might be wishing it didn’t share a name with a cryptocurrency platform after being... 
Via Benzinga
IBD/TIPP Poll: There's Bad News For Novavax's Covid Vaccine
Here's why its protein-based shot could struggle in the U.S. 
Via Investor's Business Daily
5 Biotech Stocks To Watch During The Week Of June 13
Biotech stocks continued to be under pressure in the past week amid broader market weakness, precipitated by economic worries. Company-specific developments also triggered downward moves. Here's a... 
Via Benzinga
7 Great ETFs to Buy Now for Momentum in Q2
These seven ETFs to buy are among the best funds. YPS, BITQ, FMET, QQMG, DVY, XSD, and VHT can make excellent investments. 
Via InvestorPlace
Relief May Soon Be On The Way For Diabetes Sufferers Weary Of Constant Pin Pricks, According To This Company
Last year was the 100th anniversary of the discovery of insulin, which was instrumental in improving people's lives around the world. 
Via Benzinga
What Are Whales Doing With Johnson & Johnson
Someone with a lot of money to spend has taken a bullish stance on Johnson & Johnson (NYSE:JNJ). And retail traders should know. We noticed this today when the big position showed up on publicly... 
Via Benzinga
NVAX Stock Price Predictions: Where Will Novavax Go From Here?
NVAX stock price predictions are in the spotlight after its vaccine got an unanimous recommendation from the FDA's advisory panel yesterday. 
Via InvestorPlace
CNBC's Final Trades: Starbucks, Johnson & Johnson, Union Pacific And This Way To Gain Exposure To Gold
On CNBC’s “Halftime Report Final Trades,” Stephanie Link of Hightower said Starbucks Corporation’s (NASDAQ: SBUX) U.S. 
Via Benzinga
COVID-19 Vaccine Patent Waiver Expected Soon, Says WTO Head: Reuters
 
Via Benzinga
7 Dividend Stocks to Buy for a Rich Retirement
Dividend stocks can be a good way to make money as an investor because they are likely to offer more consistent returns over time. 
Via InvestorPlace
8 Stocks Moved By Traders on 'Fast Money: Halftime Report'
CNBC’s "Fast Money: Halftime Report" delivers market-moving news to investors. The commentary delivered by hosts of the show often moves the stocks mentioned. The... 
Via Benzinga
Morning Brief: Top Financial Stories Dominating on Tuesday, June 7
Reuters 
Via Benzinga
J&J Serves Notice To Emergent For Terminating COVID-19 Shot Contract As Two Accuse Each Other Of Breach Of Agreement
Johnson & Johnson (NYSE: JNJ) has made another move towards severing its Covid-19 vaccine manufacturing ties with contract manufacturer Emergent Biosolutions, Inc. (NYSE: EBS). 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
33 34 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.